The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients

por Stemmer, Salomon M., Klang, Shmuel H., Ben-Baruch, Noa, Geffen, David B., Steiner, Mariana, Soussan-Gutman, Lior, Merling, Shahar, Svedman, Christer, Rizel, Shulamith, Lieberman, Nicky
Publicado 2013